Asceprib Injection

    Asceprib Injection

    S3

    API: Ibuprofen | Company: Ascendis Pharma

    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Management of mild to moderate pain, inflammation, and fever.

    Dosage (summary)

    400 mg to 600 mg administered as a solution for infusion, typically every 6 to 8 hours as needed, not exceeding 2400 mg per day.

    Onset of Action / Duration

    Onset of action is typically within 30 minutes, with peak effects occurring within 1 to 2 hours.

    Special Populations

    • Elderly patients
    • Patients with renal impairment
    • Patients with hepatic impairment
    • Patients with cardiovascular disease

    Pregnancy & Breastfeeding

    Use during pregnancy, especially in the third trimester, is contraindicated. Ibuprofen is excreted in breast milk; caution is advised when administering to nursing mothers.

    Key Drug Interactions

    • Increased risk of gastrointestinal bleeding with anticoagulants (e.g., warfarin).
    • May reduce the effectiveness of antihypertensive medications.
    • Increased risk of nephrotoxicity with other NSAIDs or nephrotoxic agents.

    Contraindications

    • Active peptic ulcer disease.
    • Severe heart failure.
    • History of hypersensitivity to ibuprofen or other NSAIDs.
    • Severe hepatic impairment.

    Common side effects

    • Gastrointestinal discomfort.
    • Nausea and vomiting.
    • Dizziness.
    • Headache.
    • Rash.

    Counselling Points

    • Take with food or milk to minimize gastrointestinal irritation.
    • Avoid alcohol to reduce the risk of gastrointestinal bleeding.
    • Report any signs of gastrointestinal bleeding, such as black stools or vomiting blood.
    • Inform healthcare provider of any other medications being taken.

    Serious warnings

    • Use with caution in patients with a history of gastrointestinal disease.
    • Monitor renal function in long-term use.
    • May cause cardiovascular events; use the lowest effective dose for the shortest duration necessary.
    Important Disclaimer

    The Asceprib Injection professional information leaflet below is the property of Ascendis Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn